Results 131 to 140 of about 27,503 (257)
ABSTRACT Objectives This study investigated the effect of nonsurgical periodontal therapy (NSPT) on periodontal clinical parameters, active‐matrix metalloproteinase‐8 (aMMP‐8), high sensitivity C‐reactive protein (hsCRP), and glycated hemoglobin (HbA1c), and their relationships in diabetes and prediabetes patients with periodontitis.
Kehinde Adesola Umeizudike +8 more
wiley +1 more source
Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Acute Kidney Injury in Patients With Diabetes Mellitus: A Disproportionality Analysis Based on the FAERS. [PDF]
Ohyama K +3 more
europepmc +1 more source
Abstract Background Understanding periodontal diseases through a biological lens has been a central aim in periodontal research. Visionary pioneers in the field established the foundations of our knowledge, providing invaluable insights into disease mechanisms and progression.
Nagihan Bostanci +2 more
wiley +1 more source
Abstract We tested whether older adults with well‐controlled type 2 diabetes or hypertension, compared with age‐matched adults without chronic disease, exhibit greater intestinal damage, microbial translocation and inflammation during exertional heat stress.
Ben J. Lee +8 more
wiley +1 more source
The effect of dipeptidyl peptidase-4 inhibitor on incidence and clinical course in bullous pemphigoid patients in a tertiary medical center. [PDF]
Hsu YA, Yang TT, Huang SM, Lan CE.
europepmc +1 more source
ERRATUM: Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction. [PDF]
Apaijai N +4 more
europepmc +1 more source
Repurposing dipeptidyl peptidase-4 inhibitor for Parkinson's disease prevention: A drug-target Mendelian randomization study. [PDF]
Lee JY, Park DG, Sung J.
europepmc +1 more source
Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor. [PDF]
Kano Y, Kato M.
europepmc +1 more source
Class effect beyond glucose: Implications of the LEGEND‐T2DM findings for cardiovascular outcomes
Journal of Diabetes Investigation, EarlyView.
Yuexing Liu, Weiping Jia
wiley +1 more source
Abstract The antihypertensive mechanism of sodium–glucose cotransporter 2 (SGLT2) inhibitors has been traditionally attributed to osmotic diuresis. However, emerging evidence reveals multifaceted mechanisms beyond diuresis, including regulation of the renin–angiotensin–aldosterone system, sympathetic nervous system suppression, ion homeostasis ...
Chunxiang Xu +5 more
wiley +1 more source

